Integrated approaches to reduce alcohol use in people with liver disease: a scoping review and quantitative analysis

Andrea N Weber; Marcus Osman; Laurel Smeins; Sahil Chawla; Mary M Thomas; Stephan Arndt; Nicholas L Bormann

doi:10.1093/alcalc/agaf066

Back

Integrated approaches to reduce alcohol use in people with liver disease: a scoping review and quantitative analysis

Journal article

Open access

Peer reviewed

Integrated approaches to reduce alcohol use in people with liver disease: a scoping review and quantitative analysis

Andrea N Weber, Marcus Osman, Laurel Smeins, Sahil Chawla, Mary M Thomas, Stephan Arndt and Nicholas L Bormann

Alcohol and alcoholism (Oxford), Vol.60(6), agaf066

09/16/2025

DOI: 10.1093/alcalc/agaf066

PMCID: PMC12596119

PMID: 41206096

Appears in UI Libraries Support Open Access

Files and links (1)

url

https://doi.org/10.1093/alcalc/agaf066View

Published (Version of record) Open Access

Abstract

Alcohol-associated liver disease (ALD) and alcohol use disorder (AUD) are interconnected and highly prevalent. Integrating substance use disorder (SUD) treatment into medical clinics may increase access to specialized care and improve liver-related outcomes. A scoping review and quantitative analysis were completed on published literature before 4 September 2024. Included articles described SUD treatment integrated in medical settings for adults with liver disease and alcohol use. Specific focus in the analysis was placed on integrations that utilized telehealth formats, facilitated access to medications for AUD (MAUD), and intervened in liver transplant populations. Twenty-three full-length manuscripts and 10 conference abstracts met the inclusion criteria. Fourteen articles discussed MAUD access in ALD populations. Nine utilized telehealth interventions, and 12 focused on pre- and post-liver transplant populations considered high-risk for returning to alcohol use. Nine full-length manuscripts were included in a quantitative analysis, which showed a 9.7% risk difference (95% CI: 5.9-13.4) in any alcohol use, favoring integrated care over treatment as usual. Integrated care for AUD and concurrent ALD populations can effectively reduce returns to alcohol use and be successfully integrated in a medical setting. The core ingredient of such interventions was the inclusion of an addiction medicine specialist into a medical setting, rather than an outside referral. Strategic telehealth utilization can further reduce geographic and specialty-specific barriers to SUD care in medically ill populations. More consensus is needed on key components, processes, and optimal outcomes for such integrated programs for people with concurrent liver disease and AUD.

Telemedicine

Alcohol Drinking - prevention & control

Alcoholism - complications

Alcoholism - epidemiology

Alcoholism - therapy

Delivery of Health Care, Integrated

Humans

Liver Diseases, Alcoholic - complications

Liver Diseases, Alcoholic - therapy

UIOWA OA Agreement

Details

Title: Subtitle: Integrated approaches to reduce alcohol use in people with liver disease: a scoping review and quantitative analysis
Creators: Andrea N Weber - University of Iowa
Marcus Osman - University of Iowa
Laurel Smeins - University of Iowa Health Care
Sahil Chawla - University of Iowa
Mary M Thomas - University of Iowa
Stephan Arndt - University of Iowa
Nicholas L Bormann - Mayo Clinic
Resource Type: Journal article
Publication Details: Alcohol and alcoholism (Oxford), Vol.60(6), agaf066
DOI: 10.1093/alcalc/agaf066
PMID: 41206096
PMCID: PMC12596119
NLM abbreviation: Alcohol Alcohol
ISSN: 0735-0414
eISSN: 1464-3502
Publisher: Oxford University Press
Grant note: 1H79TI085118 / SAMHSA HHS
Language: English
Date published: 09/16/2025
Academic Unit: Psychiatry; Biostatistics; Addiction Medicine; Nursing; Injury Prevention Research Center; Hardin Library; University College Courses; Internal Medicine
Record Identifier: 9985027352102771

Metrics

36 Record Views